Literature DB >> 1660641

Cellular and molecular mechanisms in the regulation and function of osteoclasts.

T J Chambers1, T J Hall.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1660641     DOI： 10.1016/s0083-6729(08)60682-2

Source DB:  PubMed          Journal:  Vitam Horm        ISSN： 0083-6729            Impact factor:   3.421


× No keyword cloud information.
  12 in total

Review 1.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

Review 3.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Calcitonin and calcitonin receptors.

Authors:  Laura Masi; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

5.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis.

Authors:  T J Hall; B Jagher; M Schaeublin; I Wiesenberg
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

7.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

8.  Taxol inhibits osteoclastic bone resorption.

Authors:  T J Hall; H Jeker; M Schaueblin
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

9.  Promethazine inhibits osteoclastic bone resorption in vitro.

Authors:  T J Hall; M Schaueblin
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

10.  Hydrochlorothiazide inhibits osteoclastic bone resorption in vitro.

Authors:  T J Hall; M Schaueblin
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.